Conduit Pharmaceuticals Inc

Analysts Viewpoint

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Conduit Pharmaceuticals

Stock Earnings

In a filing, Conduit Pharmaceuticals Inc revealed its 10% Owner Nirland Ltd unloaded Company’s shares for reported $0.16 million on

Stock Earnings

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Conduit Pharmaceuticals

Insiders Updates

Conduit Pharmaceuticals Inc’s filing revealed that its 10% Owner Nirland Ltd unloaded Company’s shares for reported $0.16 million on Oct

Stock Earnings

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Insiders Updates

Conduit Pharmaceuticals Inc’s filing revealed that its 10% Owner Nirland Ltd unloaded Company’s shares for reported $0.16 million on Oct

Analysts Viewpoint

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Analysts Viewpoint

Conduit Pharmaceuticals Inc’s recent filing unveils that its 10% Owner Nirland Ltd unloaded Company’s shares for reported $0.16 million on

Insiders Updates

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Insiders Updates

Conduit Pharmaceuticals Inc’s recent filing unveils that its 10% Owner Nirland Ltd unloaded Company’s shares for reported $0.16 million on

Tag: Conduit Pharmaceuticals Inc